
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 Department of Radiation Oncology, 2 Clinical Study Coordination and Biostatistics, 3 Division of Cancer Genomics and Proteomics, Princess Margaret Hospital, Toronto, Canada, 4 Department of Applied Molecular Oncology, 5 Division of Signaling Biology, Ontario Cancer Institute, Toronto, Canada, Departments of 6 Medical Biophysics, 7 Laboratory Medicine and Pathobiology, and 8 Computer Science, University of Toronto, Toronto, Canada, and 9 Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria
Requests for reprints: Anthony Fyles, Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada.
Purpose: To explore intratumor heterogeneity in gene expression profiles from patients with cervical cancer.
Experimental Design: A total of 33 biopsies were obtained from 11 patients, sampling between two and five different areas for each tumor. The extracted RNA was hybridized onto the Affymetrix U133 Plus 2.0 oligonucleotide chip. The variance of expression within a patient (W), between patients (B) and the total variance (T = W + B) were calculated for each ProbeSet, and the ratio W/T was used as a measure of intratumor heterogeneity. Gene Ontology functional analysis was done to assess the function of genes that had high W/T (top 10%) and low W/T (bottom 10%) values.
Results: In total, 448 ProbeSets (2.2% of the total) had W/T < 0.10, indicating low intratumor heterogeneity, and 537 ProbeSets (2.7% of the total) had W/T > 0.90, indicating high intratumor heterogeneity. In total 14,473 ProbeSets (72.4%) had higher intertumor than intratumor heterogeneity (W/T < 0.5). Genes with low intratumor heterogeneity were characterized by a statistically significant enrichment of immune-related functions (P < 0.0001). Genes with high intratumor heterogeneity were characterized by a significant tendency towards nuclear localization and nucleic acid binding (both P < 0.0001). For genes with W/T > 0.5, more than six biopsies would be required to minimize the intratumoral heterogeneity to <0.15; if W/T is 0.3 to 0.4, four biopsies are required; and for low W/T of 0.16 to 0.3, only two to three biopsies would be needed.
Conclusion: Although the intratumor heterogeneity was low for the majority of the tested ProbeSets, for many genes, multiple biopsies are required to obtain a reliable estimate of gene expression.
This article has been cited by other articles:
![]() |
Y. Zhai, R. Kuick, B. Nan, I. Ota, S. J. Weiss, C. L. Trimble, E. R. Fearon, and K. R. Cho Gene Expression Analysis of Preinvasive and Invasive Cervical Squamous Cell Carcinomas Identifies HOXC10 as a Key Mediator of Invasion Cancer Res., November 1, 2007; 67(21): 10163 - 10172. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. BANYARD, L. M. HUTCHINSON, and B. R. ZETTER Thymosin beta-NB Is the Human Isoform of Rat Thymosin beta15 Ann. N.Y. Acad. Sci., September 1, 2007; 1112(1): 286 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, T. Kuwai, Y. Kitadai, T. Sasaki, D. Fan, K. R. Coombes, S.-J. Kim, and I. J. Fidler Zonal Heterogeneity for Gene Expression in Human Pancreatic Carcinoma Cancer Res., August 15, 2007; 67(16): 7597 - 7604. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |